NCT03516435

Brief Summary

This experiment is expected to understand the benefits of different settings of electrical stimulation in the treatment of overactive bladder.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 9, 2018

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 4, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2019

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

8 months

First QC Date

April 24, 2018

Last Update Submit

May 14, 2018

Conditions

Keywords

Intravaginal electrical stimulationParasacral transcutaneous electrical stimulation

Outcome Measures

Primary Outcomes (1)

  • 3 Days Voiding diary

    This chart is a record of your voiding and leakage or urine. Choose three (3) separate 24 hour periods to complete this record. Pick days which will be most convenient for you to measure every void.

    3 days

Secondary Outcomes (3)

  • Overactive Bladder Symptom Score( OABSS)

    20 min

  • minVisual analogue scale (VAS) for urgency

    10 min

  • Pad test

    20min-1hr

Study Arms (2)

Parasacral transcutaneous ES

EXPERIMENTAL

20min./session, 2 sessions/week ,12 sessions of Parasacral transcutaneous electrical stimulation.

Device: Parasacral transcutaneous electrical stimulation

Intravaginal electrical stimulation

ACTIVE COMPARATOR

20min./session, 2 sessions/week ,12 sessions of Intravaginal electrical stimulation.

Device: Intravaginal electrical stimulation

Interventions

Asymmetrical biphasic square current pulse Frequency:10 Hz pulse width:1.0 ms Intensity:highest tolerable intensity(≦80 mA.) Parasacral transcutaneous electrical stimulation:Clinic using 2 superficial 3.5 cm electrodes placed on each side of S3 and S4.

Parasacral transcutaneous ES

Asymmetrical biphasic square current pulse Frequency:10 Hz pulse width:1.0 ms Intensity:highest tolerable intensity(≦80 mA.) Intravaginal electrical stimulation:The electrode plug for vaginal plug was cylinder-formed with ring-formed placed into vaginal.

Intravaginal electrical stimulation

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Urinary incontinence due to detrusor overactivity
  • No patients had been taking anticholinergics or tricyclic depressants and none had been treated by pelvic floor exercise, bladder training, or pelvic surgery before entry into the study.

You may not qualify if:

  • stress incontinence
  • urinary tract infection
  • neurological disease
  • genital prolapse higher than stage II on POP-Q system
  • pregnancy
  • diabetes mellitus
  • a history of anti-incontinence surgery and/or prolapse repair
  • pelvic tumors and previously treated with radiation therapy or antimuscarinic agents
  • patients who were not cooperative
  • electrical stimulation contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chung Shan Medical University Hospital

Taichung, 40201, Taiwan

RECRUITING

Study Officials

  • Chen Gin-Den, PhD

    Chung Shan Medical University

    STUDY CHAIR
  • Chen Yi-Ching, MS

    Chung Shan Medical University

    STUDY DIRECTOR
  • Chang Chia-Yun, MS student

    Chung Shan Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chen Gin-Den, PhD

CONTACT

Chen Yi-Ching, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 24, 2018

First Posted

May 4, 2018

Study Start

April 9, 2018

Primary Completion

November 30, 2018

Study Completion

February 28, 2019

Last Updated

May 17, 2018

Record last verified: 2018-05

Locations